Medical oncologist Jia Li

Jia Li, MD, PhD

Gastrointestinal Medical Oncologist

My Role at MSK

Areas of Expertise

My Specialties

  • Gastrointestinal Malignancies

Request an Appointment

Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Share

About Me

What I Do at MSK
  • Associate Attending Physician
Get To Know Me

I am a board-certified medical oncologist who specializes in caring for people with gastrointestinal cancers. These include colorectal cancer, hepatobiliary cancer, esophageal cancer, stomach cancer, and pancreatic cancer.

I see patients at Memorial Sloan Kettering Commack. I feel privileged to provide state-of-the-art care to our patients close to home on Long Island.

Read more

 

As a member of MSK’s Gastrointestinal Oncology Service, I am part of a team of experts from different areas. My colleagues include medical oncologists, surgical oncologists, radiation oncologists, radiologists, psychiatrists, oncology nurses, social workers, and dieticians. 

We provide our patients with the highest-quality care. We also offer access to many cancer clinical trials at MSK Commack and help patients enroll in studies based at MSK in Manhattan. 

My research has focused on developing new therapies for gastrointestinal cancers. I am currently a lead and co-lead author for several early-phase trials for pancreatic cancer, gastric cancer, and esophageal cancer. I also have written several book chapters on cancer care.

My Role at MSK

A gastrointestinal (GAS-troh-in-TES-tih-nul) oncologist is a cancer doctor with special training in the gastrointestinal (GI) system. This includes anal, colorectal, esophageal, gastric (stomach), liver, and pancreatic cancers, as well as GI stromal tumors and neuroendocrine tumors.

Areas of Expertise

My Specialties

  • Gastrointestinal Malignancies
Education & Honors

Education

  • MD, Tianjin Medical University

Residencies

  • Internal Medicine - Albert Einstein College of Medicine

Fellowships

  • Medical Oncology/Hematology - Yale Cancer Center

Board Certifications

  • Internal Medicine
  • Medical Oncology and Hematology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Aetna

In Network Coverage Type
HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (MTA retirees only)

In Network Coverage Type
PPO

Blue Cross Blue Shield Federal Employee Program

In Network Coverage Type
HMO, PPO

Blue Cross Blue Shield New York

In Network Coverage Type
PPO, POS, EPO, HMO

Blue Cross Blue Shield states outside of NY/NJ

In Network Coverage Type
HMO, EPO PPO, POS

Blue Cross Health Plus

In Network Coverage Type
HMO

Carrum Health

In Network Coverage Type
Supplemental

Cigna

In Network Coverage Type
PPO, POS, HMO

Connecticare

In Network Coverage Type
POS, EPO, HMO

Emblem

In Network Coverage Type
PPO, POS, EPO, HMO

Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.

Emblem Essential

In Network Coverage Type
HMO

Emblem Medicare Advantage

In Network Coverage Type
PPO, HMO

Empire Blue Cross Medicare Advantage

In Network Coverage Type
PPO, HMO, DSN

Empire Essential

In Network Coverage Type
HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

In Network Coverage Type
PPO

Fidelis

In Network Coverage Type
HMO, EPO

Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.

Fidelis Managed Medicaid & HARP

In Network Coverage Type
HMO

Fidelis Medicare Advantage

In Network Coverage Type
HMO

First Health

In Network Coverage Type
PPO

Healthfirst

In Network Coverage Type
EPO, HMO, PPO, POS

Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.

Healthfirst Managed Medicaid

In Network Coverage Type
HMO

Healthfirst Medicare Advantage

In Network Coverage Type
HMO, PPO

Healthsmart

In Network Coverage Type
PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

In Network Coverage Type
HMO

Horizon Blue Cross Blue Shield New Jersey (PPO)

In Network Coverage Type
PPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

In Network Coverage Type
EPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

In Network Coverage Type
EPO

Horizon Medicare Advantage

In Network Coverage Type
PPO, HMO

Husky CT Medicaid

In Network Coverage Type
State Government

Magnacare

In Network Coverage Type
PPO, POS, EPO

Straight NJ Medicaid

In Network Coverage Type
State Government

Straight NY Medicaid

In Network Coverage Type
State Government

Medicare Part A&B (traditional Medicare)

In Network Coverage Type
Federal Government

Multiplan/Beech Street/PHCS

In Network Coverage Type
Supplemental

MVP

In Network Coverage Type
PPO/OAP

Non-Participating Plans with Out of Network Benefits

In Network Coverage Type
PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

In Network Coverage Type
TBD

Oscar

In Network Coverage Type
HMO/EPO

Oxford

In Network Coverage Type
PPO, EPO

World Trade Center Health Program (WTC)

In Network Coverage Type
State Government

Qualcare

In Network Coverage Type
PPO, POS, HMO

Tricare

In Network Coverage Type
PPO, HMO

UMR

In Network Coverage Type
PPO, POS

United Healthcare

In Network Coverage Type
PPO, POS, HMO

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients

Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.

Contact and Location

Dr. Li sees patients at one location.

Office Phone
Location
Commack, NY

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Gastrointestinal Oncology Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Peer-Reviewed Articles

Li J, Kluger H, Lesley D, et al. Phase I Study of Safety and Tolerability of Sunitinib in Combination with Sirolimus in Patients with Refractory Solid Malignancies and Determination of VEGF (VEGF A) and soluble VEGF-R2 (sVEGFR2) in plasma. Cancer Chemotherapy and Pharmacology. 2016, Apr 21 [Epub ahead of print]

Stein SM, James ES, Deng Y, Cong X, Kortmansky JS, Li J, et al. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. Br J Cancer. 2016;114(7):809-12.

Read more

Li J, Yao X, Kortmansky JS, et al. Phase II study of modified FOLFOX6 with bevacizumab in metastatic gastroesophageal adenocarcinoma. AJCO. 2014 Aug 20 (Epub ahead of print).

Saif MW, Li J, Lamb L, et al. First-in-human Phase II Trial of the Botanical Formulation PHY906 with Capecitabine as Second-line Therapy in Patients with Advanced Pancreatic Cancer. Cancer Chemother Pharmacol. 2014;73(2):373-380

Zhang X, Li J. Era of universal testing of microsatellite instability in colorectal cancer. World J Gastrointest Oncol. 2013;5(2):12-9.

Li J, Merl MY, Lee MX, et al. Safety and efficacy of single day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience. Expert Opinion on Drug Safety. 2010;9(2):207-13.

Li J, Saif MW. Current use and potential role of bevacizumab in gastrointestinal cancers. Biologics: Target & Therapy 2009;3:429-441.

Li J, Podoltsev N, Saif MW. Management of advanced pancreatic cancer. Expert Review of Clinical Pharmacology 2009:2(5):527-541.​

Publications on PubMed

Visit PubMed for a full listing of Dr. Li’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Jia Li discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures